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Abstract
Earlier, we have shown that GM-CSF-exposed CD8a2 DCs that express low levels of pro-inflammatory cytokines IL-12 and
IL-1b can induce Foxp3+ Tregs leading to suppression of autoimmunity. Here, we examined the differential effects of IL-12
and IL-1b on Foxp3 expression in T cells when activated in the presence and absence of DCs. Exogenous IL-12 abolished,
but IL-1b enhanced, the ability of GM-CSF-exposed tolerogenic DCs to promote Foxp3 expression. Pre-exposure of DCs to
IL-1b and IL-12 had only a modest effect on Foxp32 expressing T cells; however, T cells activated in the absence of DCs but
in the presence of IL-1b or IL-12 showed highly significant increase and decrease in Foxp3+ T cell frequencies respectively
suggesting direct effects of these cytokines on T cells and a role for IL-1b in promoting Foxp3 expression. Importantly,
purified CD4+CD25+ cells showed a significantly higher ability to maintain Foxp3 expression when activated in the presence
of IL-1b. Further analyses showed that the ability of IL-1b to maintain Foxp3 expression in CD25+ T cells was dependent on
TGF-b1 and IL-2 expression in Foxp3+Tregs and CD252 effectors T cells respectively. Exposure of CD4+CD25+ T cells to IL-
1b enhanced their ability to suppress effector T cell response in vitro and ongoing experimental autoimmune thyroidits in
vivo. These results show that IL-1b can help enhance/maintain Tregs, which may play an important role in maintaining
peripheral tolerance during inflammation to prevent and/or suppress autoimmunity.
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Introduction
Cytokines play a crucial role in regulating the immune response
in that they help determine if a response to an immunogenic
stimulus leads to a potent effector response or the induction of
immune tolerance. While cytokines such as IL-10 and TGF-b
have been implicated in the induction and maintenance of
peripheral tolerance [1,2,3,4], IL-1b, IL-12, IL-6, IL-17, TNF-a
and IFN-c have been generally identified with inflammatory and
autoimmune responses [5,6,7,8,9,10]. These cytokines are secreted
by different types of immune cells including dendritic cells (DCs).
The nature of the immune response initiated by the DCs is
dependent on a number of factors including the types of cytokines
they produce, their maturation status, and the nature of the
antigen they present [11,12,13,14,15,16]. Immature and semi-
mature DCs and anti-inflammatory cytokines produced by them
promote peripheral tolerance through regulatory T cells (Tregs)
[17,18,19].
Tregs are subpopulations of T lymphocytes that express the
transcription factor Foxp3 and they help maintain immunological
self-tolerance in the periphery and prevent autoimmunity. Tregs
are divided into two types: naturally occurring Tregs derived from
thymus (nTregs) and Tregs induced in the periphery (induced or
adaptive Tregs) [20,21,22]. Although the mechanism of induction of
Foxp3+ T cells and maintenance of thymus derived nTreg
function in the periphery have not been completely elucidated, a
critical role for cytokines such as TGF-b1 has been implicated
[3,23,24,25]. Recent studies have confirmed a role for IL-2 in the
development, homeostasis as well as effective functioning of Tregs
[26,27]. In addition, non-activated and/or partially activated DCs
can help maintain effective Treg function in the periphery [18,
28,29]. On the other hand, pro-inflammatory cytokines and highly
activated DCs are known to abrogate the function of both popu-
lations of Tregs leading to breakdown of self-tolerance and
induction of autoimmunity [5,8,9,30,31].
DCs that produce significantly low levels of inflammatory
cytokines and/or higher amounts of anti-inflammatory cytokines
are known to induce and/or expand Foxp3+ Tregs in the peri-
phery [32,33,34]. In our earlier studies we showed that DCs of
mice that were treated with GM-CSF were resistant to maturation
even when exposed to inflammatory agents such as complete
Freund’s adjuvant (CFA) and maintain semi-mature tolerogenic
phenotype, induce Tregs, and suppress autoimmunity upon im-
munization with self-antigens [19,35,36,37]. Further studies have
shown that this tolerogenic effect of GM-CSF exposed DCs on T
cells is associated with suppressed levels of inflammatory cytokines
such as IL-1b and IL-12 [19,37,38]. Therefore, the current study
was initiated to understand the relative importance of IL-1b and
IL-12 in influencing Foxp3+ Treg induction and/or expansion
upon T cell activation in the presence of GM-CSF exposed
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hitherto considered a pro-inflammatory cytokine, could promote
Foxp3+ expression in activated T cells. On the other hand, IL-12
abrogated Foxp3 induction in activated T cells. Further analyses
showed that IL-1b can exert an adjuvant effect on TGF-b1 and
IL-2 dependent maintenance of Foxp3+ Tregs. Collectively, our
results show a unique role for IL-1b in promoting and maintaining
Treg function.
Materials and Methods
Mice
Six- to 8-week-old female CBA/J, CD45.1 and wild type C57/
B6 mice were purchased from the Jackson Laboratory (Bar
Harbor, ME). Foxp3-GFP KI mice (CD45.2) were kindly provided
by Dr. Vijay Kuchroo, Harvard Institutes of Medicine. Mice were
housed and bred in the College of Medicine Research building
at the University of Illinois (Chicago, IL) and provided food
and water ad libitum. Animals were cared for in accordance with
the University of Illinois Animal Care and Use Committee
guidelines.
GM-CSF & Abs
Recombinant mouse-GM-CSF was purchased from Invitrogen
(Carlsbad, CA). The FITC or APC-conjugated anti-CD11c
(N4181), CD8a (53-6.7), CD25 (3C7), CD80 (16-10A1), CD86
(GL-1) and CD40 (3/23), FITC-labeled CD4, streptavidin PE,
isotype control monoclonal Abs, biotinylated anti-TGF-b Ab
(A75-3), and purified anti-CD16/CD32R Ab (2.4G2), as Fc
receptor block, were purchased from BD Biosciences Pharmingen
(San Diego, CA). APC or EF anti-Foxp3 (FJK-16S), PE- anti IL2
(JES6-5H4), PE anti-CD4 (GK1.5), PE anti-IL-10 (JES5-16E3),
APC anti-IL-17 (ebio17B7) Abs were obtained from eBioscience
(San Diego, CA). CFSE was purchased from Invitrogen and
neutralizing Abs to TGF-b (1D11), IL-2 (MAB702), IL1R1
(JAMA147), anti-IL-12 (polyclonal), were purchased from R&D
Systems (Minneapolis, MN).
T cells, DCs and mouse thyroglobulin
CD4+25+ and CD4+CD252 T cells were purified from
spleen by positive and negative selection, respectively, using Abs
conjugated to magnetic beads (Miltenyi Biotec, Auburn, CA). For
isolation of Foxp3+GFP+ and Foxp3-GFP- cells, CD4+ T cells
were first isolated from spleens of eGFP-Foxp3 knock in mice
using negative selection kit (Miltenyi Biotec) followed by cell
sorting for GFP+ and GFP- cells using the MoFlo cell sorter
(DakoCytomation). For some experiments, these cells were stained
with PE-labeled anti-CD25 Abs and further sorted based on their
expression of GFP and CD25. CD11c+ DCs were first isolated
from spleens by positive selection using anti-CD11c Ab-labeled
magnetic beads, and CD8a+ and CD8a2 DCs were further
purified using the MoFlo cell sorter after staining with fluoro-
chrome-labeled anti-CD11c and anti-CD8a Abs. Normal mouse
thyroids were obtained from BiochemMed (Winchester, VA) or
were isolated from mice during necropsy and the mTg was
prepared as described earlier [39].
GM-CSF treatment and immunization with thyroglobulin
Mice were given intra-peritoneal (i.p.) injections of GM-CSF
(2 mg/mouse/day) for 5 consecutive days, from days 1–5 and 15–
19. Control mice received PBS. Mice were immunized subcuta-
neously (s.c.) with mTg (100 mg/mouse) emulsified in complete
Freund’s adjuvant (CFA, Sigma) on days 6 and 20.
Effects of GM-CSF treatment on DC maturation
GM-CSF-treated and control mice were sacrificed 48 h after
mTg immunization. Purified CD8a+ and CD8a2 DCs were
obtained from spleens and RNA for RT-PCR was isolated from
these purified DC populations using Trizol (Invitrogen). Cytokine
transcript levels for IL-10, IL-6, TNF-a, IL-1b, and IL-12 were
determined by RT-PCR using a commercial kit following
manufacturer’s guidelines (Maxim Biotech, Rockville, MD.).
IL-12 and IL-1b treatment of DCs
Isolated splenic CD11c+CD8a2 DCs were treated with IL-1b
or IL-12 (e-bioscience) for 24 hours. These cells were then stained
with fluorochrome-labeled anti-mouse CD11c Ab in combination
with anti-mouse CD80, CD86 or CD40 Abs and analyzed using a
flow cytometer (Cyan; DakoCytomation). Supernatants from these
cultures were tested for cytokines by ELISA. For some experi-
ments, these DCs were washed and cultured with T cells in
antigen-presentation assays.
In vitro cell culture assay
Purified total CD4+ T cells, or sorted CD4+25+ or CD4+252
T cells (4610
4 cells/well) were cultured with or without the
addition of soluble anti-CD3 and anti-CD28. For some experi-
ments, CD4+GFP+ and CD4+GFP2 T cells isolated from GFP-
KI mice were used. For certain co-culture experiments, CD4+
GFP+ or CD4+GFP2 T cells of CD45.2 mice were co-cultured
with CD4+CD252 or CD4+CD25+ T cells from CD4+CD45.1 T
cells in the presence of anti-CD3 and anti-CD28 Abs. In some
experiments, CD4+ T cells were cultured with DCs either in the
presence of IL-1b or DCs that had been previously exposed to
IL-1b. In other experiments the T cells were co-cultured in the
presence of GMCD8a2 DCs or ConCD8a2 DCs at different
ratios. Twenty four hours later, medium, IL-12 or IL-1b, or both
were added at concentrations specified in the legend. After a total
of 5 days in culture, cells were analyzed by flow cytometry. In
some experiments, these cells were stained with CFSE and
assessed for their ability to proliferate. For the 3H-TdR-based
proliferation assays, cells were pulsed for the last 18 h of culture
with 1 mCi 3H-thymidine after which they were harvested and
assessed for thymidine incorporation. In some experiments,
neutralizing Abs to TGF-b, IL-12 or IL-1b were added to the
cultures at specified concentrations. All results are expressed as the
mean cpm 6SD of triplicate cultures. Cell-free supernatants were
collected for cytokine analysis by ELISA.
Measurement of cytokine production
Cell free supernatants were assayed for IFN-c, IL-2, IL-10,
TGF-b, IL-12 and IL-1b by sandwich ELISA using paired Abs
following the manufacturer’s instructions (eBioscience). The OD
values were determined at 450 nm using a microplate reader (Bio-
Rad). Cytokine levels were determined using corresponding cyto-
kine standards.
Evaluation of EAT
Thyroids were fixed in formalin, embedded in paraffin,
sectioned across both lobes and stained with H&E. Thyroid
pathology was evaluated and the extent of thyroid lymphocytic
infiltration, as a marker of disease severity, was scored using a scale
of 1+ to 5+. An infiltrate of at least 125 cells in one or several foci
was scored 1+. Ten to twenty foci of cellular infiltration involving
up to 25% of the gland was scored 2+. An infiltration involving up
to 25–50% of the gland was scored 3+. Destruction of greater than
50% of the gland was scored 4+, and near complete destruction of
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Thyroids were evaluated and scored in a blinded fashion.
Statistical analysis
Mean, standard deviation, and statistical significance were cal-
culated using the SPSS application software. Statistical significance
was determined using the non-parametric paired t test. In most
cases, values of individual treated and/or immunized groups were
compared with that of untreated and/or non-immunized group
unless mentioned otherwise. In studies comparing more than two
groups, one-way analysis of variance was used to determine p
values and assess significance. A p value of ,0.05 was considered
significant.
Results
IL-1 b and IL-12 produce contrasting effects on Foxp3
expression in activated T cells
Earlier, we have shown that mice treated with GM-CSF carry
large numbers of CD8a2 tolerogenic DCs with the ability to
induce and/or expand antigen specific Foxp3+ Tregs and suppress
autoimmunity [19]. We have also reported that CD8a2 DCs
from GM-CSF treated mice produce significantly lower amounts
of pro-inflammatory cytokines IL-1b and IL-12 compared to their
counterparts from control mice when exposed to inflammatory
agents such as CFA [19,37,38] indicating that suppressed levels of
these cytokines have a positive effect on the ability of DCs to
induce Foxp3 expression in T cells upon activation. Hence, the
influence of IL-1b and IL-12 during T cell activation by DCs in
terms of Foxp3 expression in T cells was examined.
Consistent with our earlier reports, DCs from GM-CSF treated
mice expressed considerably lower levels of IL-1b and IL-12
compared to DCs from untreated mice (Fig. 1A). Mouse
thyroglobulin (mTg) pulsed DCs from GM-CSF treated and
control mice were cultured with purified T cells from mTg
primed-mice with or without IL-12 and/or IL-1b. As seen in
Figure 1B, IL-12 supplemented culture had significantly lower
numbers of Foxp3+ T cells compared to control wells irrespective
of the type of DCs used (Fig. 1B). This suggested that suppressed
levels of IL-12 might be contributing to the ability of GM-CSF
exposed DCs to induce/expand Foxp3+ T cells. However, addi-
tion of IL-1b to these antigen presentation assay wells resulted in a
significant increase in frequencies of Foxp3+ T cells over controls
that did not receive any exogenous cytokine (Fig. 1B,P ,0.01).
These results suggested that suppressed IL-12, but not IL-1b,
production by GM-CSF-exposed DCs conferred tolerogenic
properties to DCs, which can be further enhanced by IL-1b.I n
addition, these results showed that the effects of exogenous IL-12
and IL-1b are similar on both the control and the GM-CSF
exposed DCs in terms of their ability to influence Foxp3 ex-
pression in T cells. Hence the rest of the study was carried using
control DCs to understand the differential effects of these
cytokines.
Neither IL-12 nor IL-1b treatment significantly alters the
phenotype and antigen presenting properties of DCs
From the above described experiment it was apparent that
exogenous IL-12 and IL-1b could influence the ability of both
control and GM-CSF-exposed DC’s to affect Foxp3 expression in
T cells suggesting that the effects of these cytokines may not be on
the DCs themselves but primarily on T cells. In order to confirm
this and to examine if the cytokines secreted by DCs have an
autocrine/paracrine effect on the activation state of DCs that can
in turn influence the T cell function, we examined CD8a2 DCs
that were cultured with and without IL-12 and IL-1b for
expression levels of co-stimulatory molecules. Fig. 2A shows
that surface expression levels of co-stimulatory molecules CD80,
CD86, CD40, PDL-1 and PDL-2 remained largely unaltered after
treatment with either cytokine. In addition, IL-12 and IL-1b-
treated DCs showed similar cytokine profiles to that of untreated
DCs (not shown). To test the ability of cytokine-exposed DCs to
influence Foxp3 expression in T cells, CD4+ T cells were activated
using anti-CD3 Ab in the presence of these DCs and examined for
Foxp3 expression. As observed in Fig. 2B, continuous presence of
these cytokines in DC:T cell cultures, but not exposure of DCs to
cytokines prior to their addition to the culture, produced signifi-
cant effect on the ability of T cells to express Foxp3. T cell:DC
cultures, in which IL-1b was continuously present, showed a
significantly higher number of Foxp3+ T cells compared to
cultures where cytokine pre-exposed DCs were used. On the other
hand, significantly fewer numbers of T cells activated in the
presence of DCs and IL-12 expressed Foxp3 compared to T cells
activated in the presence of IL-12 pre-exposed DCs. The
expression of the IL-1b receptor (IL-1R2) was however detected
on both DCs as well as T cells with and without treatment with IL-
1b (Supporting figure 1). These observations strongly indicated
that the primary and direct effects of IL-1b and IL-12 are on T
cells.
IL-1b acts directly on T cells and affects Foxp3 and
TGF-b1 expression in them in a concentration dependent
manner
To further confirm the direct effect of IL-1b and IL-12 on T
cells in terms of Foxp3 expression, purified CD4+ T cells were
activated using anti-CD3 and CD28 Abs in the absence of DCs,
but in the presence of varying amounts of these cytokines. As
observed in Fig. 3A, the frequency of T cells that expressed Foxp3
was highest when they were activated in the presence of an
optimum amount of (5 ng/ml) IL-1b. In contrast, a majority of T
cells lost Foxp3 expression when they were activated in the
presence of IL-12 irrespective of the concentration of this cytokine
in the culture (lower right panel). Of note, this effect of IL-12 on
Foxp3 expression in T cells was persistent even at picogram
concentrations (data not shown). These observations further
demonstrate that IL-1b and IL-12 act directly on T cells and
influence Foxp3 expression in them.
Addition of optimum amount of IL-1b to T cell activation
cultures also resulted in a significant increase in the frequency of
TGF-b expressing T cells (Fig. 3A, lower left panel) compared to T
cells activated in the absence of exogenous IL-1b (Fig. 3A, upper
panel). In contrast, when IL-12 was added to the culture, there was
a significant decrease in the TGF-b1+ T cell frequency in the
culture as compared to controls. Furthermore, the amounts of
TGF-b1 secreted in the culture supernatants were significantly
higher in IL-1b, but lower in IL-12 supplemented T cell activation
cultures (Fig. 3B). Addition of IL-1b 24 hours after activation
yielded the highest percentage of Foxp3+ T cells when compared
to cultures that received no IL-1b or received it on day 0 or
48 hours after activation (Fig. 3C). Although, the exact mecha-
nisms involved in the increase in Foxp3+ T cells that received IL-
1b 24 h after activation is not clearly known, we speculate that this
may be related to the Foxp3 promoter occupancy and therefore
unavailable for gene transcription in resting T cells. Activation of
T cells may cause the promoter to be ‘unblocked’ causing the
Foxp3 gene to become available for modulation by IL-1b. These
observations indicated that IL-1b and IL-12 can directly act on T
cells upon activation and modulate Foxp3+ and TGF-b1
expression. Since earlier studies have implicated TGF-b in the
IL-1b Helps Maintain Foxp3+ Tregs
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in the Foxp3+ T cell frequencies when the T cell cultures were
supplemented with IL-1b and IL-12 could be a consequence of
altered levels of secreted TGF-b1. These observations also suggested
that optimal concentrations of IL-1b can promote Treg function.
Hence the effects of IL-1b on Tregs in terms of Foxp3 expression
and suppressor function were examined as described below.
IL-1b helps maintenance of Foxp3 expression in
CD4+CD25+ T cells upon activation
To examine whether IL-1b acts on natural Foxp3+ Tregs and
causes their expansion or induces Foxp3 expression in effector T
cells upon activation, CD4+CD25+ and CD4+CD252 T cells
were enriched from naive mice (Fig. 4A) and activated using anti-
CD3 and anti-CD28 Abs in the presence of optimum concentra-
tion of IL-1b . Consistent with the observations shown in Fig. 3,
significantly higher number of total CD4+ T cells activated in the
presence IL-1b expressed Foxp3 and TGF-b1 compared to those
cells activated without IL-1b (Fig. 4B; left panels). Notably, only
about 50% of enriched CD25+ T cells expressed Foxp3 after 4
days of activation in vitro (Fig. 4B; middle panels). The reduction
seen in Foxp3 levels in CD25+ (i.e. from 75% to 47% without IL-
1b and 68% with IL-1b; see panel 4A and 4B;) as well as in
CD4+ cultures (Figs. 3 and 4) suggested that a significant number
of CD4+CD25+ nTregs lost their Foxp3 expression and/or
Foxp32 cells in enriched CD4+CD25+ population expanded
Figure 1. GM-CSF-treated DCs show suppressed levels of IL-12 and IL-1b; addition of IL-1b enhances Foxp3 expression. A, CBA/J mice
were treated with either GM-CSF or PBS for 5 consecutive days starting on days 1 and 15. Mice were immunized twice with mTg (100 mg/100 ml) and
CFA on days 6 and 20. Two days after the 2
nd immunization, mice were sacrificed and CD11c+ DCs were isolated from spleens by positive selection
using CD11c-labeled magnetic beads. CD11c+CD8a+ and CD11c+CD8a2 DCs were further purified using the MoFlo cell sorter (Beckman Coulter).
RNA was isolated from GMCD8a2 DCs and ConCD8a2 DCs and used in a RT-PCR assay to detect cytokine transcripts with a multiplex PCR kit (Maxim
Biotech). PCR products were collected at 32 and 35 cycles and were resolved on a 2% agarose gel. Densitometry analysis was performed and band
densities represented as ratios of densities relative to the GAPDH bands from the corresponding cells are represented in the bar graph. The numbers
on the X axis denotes the number of PCR cycles. B, CD4+ T cells were isolated from spleens of mTg-immunized CBA/J mice and cultured in the
presence of DCs from GM-CSF treated mice (GMCD8a2 DCs) or PBS treated control (ConCD8a2) mice (4610
4 cells/well) at a 1:1 ratio in 96-well
round bottom plates in the presence of mTg (100 mg/ml). Some wells received 5 ng/ml of IL-1b or IL-12, or both. Controls received medium alone.
After 5 days in culture, the cells were collected and stained for Foxp3 expression along with CD4 and analyzed by flow cytometry. Representative
scatter-plots of CD4+Foxp3+ cells from three independent experiments carried in triplicates, and bar graphs depicting the mean and SD values of the
percentage of Foxp3+ T cells are shown. [GMCD8a2 or ConCD8a2=Cultures of GM-CSF treated CD8a2 DCs or Control CD8a2 DCs respectively
with CD4+ T cells from mTg-primed mice that received medium alone, IL-1b or IL-12.]. One-way analysis of variance was used to determine statistical
significance. * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0021949.g001
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proportion of CD4+CD25+ T cells activated in the presence of
IL-1b expressed both Foxp3 and TGF-b1 compared to their
respective controls. This observation suggested that IL-1b sig-
naling may be contributing to the maintenance of Foxp3 expres-
sion in nTregs and/or promoting Foxp3 expression in activated
effector T cells with the help of TGF-b1. Importantly, CD4+
CD252 T cells activated in the presence of IL-1b failed to show a
significant increase in Foxp3+ and TGF-b1+ T cell frequencies
compared to their control counterparts (Fig. 4B; right panels). This
suggested that the effect of IL-1b, in terms of Foxp3 and TGF-b1
expression, is primarily on nTregs. Examination of supernatants
from the above cultures revealed that T cells activated in the
presence of IL-1b produced significantly higher amounts of not
only TGF-b1, but also IL-2, compared to cells activated without
IL-1b (Fig. 4C). Interestingly, while CD4+CD25+ population, but
not CD4+CD252 population produced large amounts of TGF-b1
when activated in the presence of IL-1b, both populations
produced significantly higher amounts of IL-2 in the presence
of IL-1b. CD4+CD25+ T cells had higher basal levels of IL-2
than expected. This is probably due to either the presence of
CD25+Foxp32 activated T cells in the culture or due to IL-2
secretion by potentially contaminating CD252 T cells as CD25+
purifications using magnetic beads yielded approximately 75%
CD25+ T cells. This suggested a potential role for IL-2 in IL-1b-
mediated TGF-b1-dependent Foxp3 expression in T cells. Foxp3+
Tregs are known to be refractive to expansion even upon acti-
vation by anti-CD3 and anti-CD28. Therefore, to understand as
to why IL-1b-treated cultures had increased Foxp3-expressing
cells, we used purified Foxp3+ Tregs from the Foxp3-GFP knock-
in mice by cell sorting and activated them with anti-CD3 and anti-
CD28. After 4 days of culture, the cells were analyzed for both
GFP as well as Foxp3 expression. The number of GFP+ T cells or
Foxp3-expressing cells recovered at the end of 4 days were very
few (,5% Foxp3+). In contrast, CD25+ T cells expressed much
higher levels of Foxp3 (47%) (Fig. 4D, right panel). This apparent
difference in the frequency of Foxp3+ cells was most likely due to
the inability of Foxp3+ cells to survive/proliferate in the absence of
IL-2, which in CD25+ cultures was likely produced by activated
non-Foxp3+ T cells. Therefore, we used CD25+ T cells in our
subsequent experiments.
IL-1b mediated increase in Foxp3+ T cells is TGF-b1 and
IL-2 dependent
In order to determine the roles of IL-1b-induced-TGF-b and
IL-2 in promoting Foxp3+ expression in T cells, purified total
Figure 2. IL-12 and IL-1b act primarily on CD4+T cells to induce Foxp3. A, Purified CD11c+ DCs were stained with fluorochrome conjugated
anti-CD11c and anti-CD8a antibodies and sorted into CD8a+ and CD8a2 sub-populations. The sorted CD8a2 population was cultured in the presence
of 5 ng of IL-1b, IL-12 or medium alone for 24 hours and subsequently stained with anti-CD80, anti-CD86, anti-CD40, anti PDL-1 or anti-PDL2 antibodies
and analyzed by flow cytometry. The percentage of cells positive for the expression of the respective co-stimulatory molecule is represented as
histograms. [Light grey filled peaks towards the left represent the isotype controls and are marked. Black lines represent controls that received medium
alone, Dark grey lines represent cultures that received IL-1b and grey-filled peaks indicate cultures that received IL-12]. B, For co-culture experiments,
sorted CD8a2 DCs were cultured in the presence of IL-1b or IL-12 for 24 hours, DCs were washed andthen cultured with CD4+ T cells and stimulated in
the presence of anti-CD3 antibody (Top row of panels). After 4 days, cells were assayed for Foxp3 expression along with CD4 using corresponding
fluorochrome-labeled antibodies by flow cytometry. In parallel cultures,theCD8a2 DCswere culturedin the presenceof CD4+ T cellsin thepresenceof
anti-CD3 (2 mg/ml) and IL-1b was added to the DC-T cell co-cultures (Lower row of panels). Foxp3 expression was assayed as described above.
Representative scatter-plots of CD4+Foxp3+ cells from two independent experiments carried out in triplicates and mean and SD of the percentages of
Foxp3 expression are shown. One-way analysis of variance was used to determine statistical significance. * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0021949.g002
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in the presence of IL-1b, and with and without neutralizing Abs to
TGF-b and IL-2. Consistent with the observations from above
experiments (Figs. 3 and 4), a significantly higher proportion of T
cells activated in the presence of IL-1b expressed Foxp3. However,
neutralization of either IL-2 or TGF-b1 using respective Abs in
these cultures resulted in complete reversal of the Foxp3-inducing
effect of IL-1b in CD4+ T cells (Fig. 5). These observations clearly
indicated that IL-1b-mediated expression of Foxp3 in T cells
requires both TGF-b and IL-2 induced signaling.
IL-1b enhances proliferative response of Foxp32 cells,
but not Foxp3+ Tregs upon activation
Foxp3+ Tregs are considered anergic and are not known to
proliferate upon stimulation with anti-CD3 and anti-CD28 Abs,
and yet we observed significantly higher Foxp3+ T cell frequencies
in IL-1b supplemented CD4+CD25+ T cell activation cultures.
To determine the effect of IL-1b on sub-populations of T
cells during activation, enriched Foxp3+CD25+, Foxp32CD25+,
Foxp3+CD252, Foxp32CD252 T cell subpopulations from
Foxp3-GFP knock-in mice (Fig. 6A; left panel) were examined for
their ability to proliferate upon activation in the presence or
absence of IL-1b . CD4+CD25+ T cells and CD4+CD252 T cells
from wild type mice (Fig. 6B) were also examined for their
proliferative response upon activation in the presence of IL-1b.A s
observed in Fig. 6C, Foxp3+ (GFP+) T cells activated with or
without IL-1b showed little or no proliferation irrespective of
surface CD25 expression. In contrast, IL-1b induced a significant
proliferation of Foxp32 (GFP2) T cell populations. Importantly,
both CD4+CD25+GFP2 and CD4+CD252GFP2 populations
showed significantly higher levels of proliferation compared to
Foxp3+ (i.e. GFP+) cells. In addition, both CD25+ and CD252
populations showed enhanced proliferative response when the
cultures were supplemented with IL-1b. These results indicated
that IL-1b promotes proliferation of CD25+ T cells, which
contains both Foxp3+ and Foxp32 cells, but cannot promote
proliferation of purified Foxp3+ cells. These results suggested that
CD4+Foxp32 T cells may have a role in maintaining Foxp3
expression in Foxp3+Tregs during activation and expansion.
These results also indicated that nTreg expansion requires addi-
tional cytokines such as IL-2 that probably comes from non-
Foxp3+ cells.
IL-1b-mediated maintenance of Foxp3 expression in
Tregs is dependent on Treg derived TGF-b1 and effector
T cell derived IL-2
Fig. 5 showed that IL-1b-mediated Foxp3 expression is TGF-b1
and IL-2 dependent. Consistent with earlier reports [34,40] our
above observations (Fig. 6) indicated that nTregs do not proliferate
upon activation using anti-CD3 Ab likely due to lack of IL-2
production. Therefore, we examined the source of cytokines
(i.e.TGF-b1 and IL-2) that contribute to Foxp3 expression in
Tregs when activated in the presence of IL-1b using nTregs
isolated from Foxp32GFP-knock-in mice (CD45.2 mice) and
CD4+CD252 effector T cells from wild-type mice (CD45.1 mice)
(Fig. 7). When GFP+(Foxp3+) CD45.2 T cells were activated using
anti-CD3 and anti-CD28 Abs, Foxp3 expression was lost in a
significant proportion of cells and IL-1b failed to influence Foxp3
expression in them significantly (Fig. 7; uppermost row). Con-
siderable number of these activated GFP+ (Foxp3+) cells expressed
TGF-b1, but not IL-2. On the other hand, when CD4+CD252
CD45.1 T cells were activated, IL-1b induced the production of
IL-2 by a large number of cells, but did not influence Foxp3 or
TGF-b1 expression in them (Fig. 7A; third row). Interestingly, co-
activation of GFP+(Foxp3+) CD45.2 and CD4+CD252 CD45.1
T cells in the presence of IL-1b led to Foxp3 and TGF-b1
expression in a significantly higher number of CD45.2 T cells
compared to co-culture of those cells in the absence of exogenous
IL-1b (Fig. 7A; second row). These observations suggested that
Foxp3 expression in Tregs upon activation is co-dependent upon
the autocrine effects of TGF-b1 and IL-2 secreted by effector T
cells, while IL-1b delivers an adjuvant effect rather than directly
inducing Foxp3 expression. Of note, a higher number of CD4+
CD252 CD45.1 T cells expressed Foxp3 in the presence of IL-1b
and GFP+(Foxp3+) CD45.2 T cells (Fig. 7A; lowermost row).
Correspondingly, increased levels of secreted TGF-b1 and IL-2
were observed in cultures of CD45.2+GFP+ T cells and CD45.1+
CD252 CD4+T cells respectively that received IL-1b as com-
pared to untreated controls (Fig. 7B).
IL-1b-exposed CD25+ T cells show superior ability to
suppress effector T cell response
To assess the functional significance of IL-1b-mediated Foxp3
expression in T cells, CD4+CD25+ T cells that were activated
using anti-CD3 and anti-CD28 Abs in the presence and absence of
IL-1b were examined for their ability to suppress effector T cell
proliferation in a co-culture assay. As observed in Fig. 8, both IL-
1b-exposed as well as control CD25+ T cells were able to suppress
the CD252 effector T cell proliferation as indicated by the CFSE
dilution profile. However, significantly fewer effector T cells in the
presence of IL-1b exposed CD4+CD25+ T cells showed CFSE
dilution compared to effector cells activated in the presence of
control CD4+CD25+ T cells at a 1:1 ratio of Tregs and effector T
cells. The differences however were no longer significant at ratios
greater than 1:2. CD252 T cells were similarly treated with or
without IL-1b and cultured with effector T cells. IL-1b had no
effect on the ‘suppressive’ ability of these cells. These results
showed that IL-1b-exposed CD4+CD25+ T cells have a superior
ability to suppress effector T cell response, perhaps due to the
presence of a higher proportion of Foxp3+ and TGF-b1+ cells.
Figure 3. The effects of IL-1b on CD4+ T cells is dose-dependent and results in increased TGF-b1 production. A, CD4+ T cells were
isolated from the splenocytes of wild type C57Bl/6. 4610
4 CD4+ T cells/well cultured in 96-well round bottom plates in the presence of 2 mg/ml of
anti-CD3 and 0.8 mg/ml of anti-CD28. Twenty four hours later, cell cultures received different concentrations of IL-1b, IL-12, or medium as mentioned.
Four days later, CD4+T cells were re-stimulated with anti-CD3 and anti-CD28 in the presence of monensin for 6 hours to prevent cytokine secretion.
Cells were subsequently analyzed for Foxp3 and TGF-b1 expression along with CD4 by flow cytometry. Representative scatter-plots of similar results
from 3 independent experiments are shown. These values were compared with cultures that received medium, and t-test was used to determine
statistical differences. p,0.05 was considered significant. B TGF-b1 levels in supernatants from cultures shown in Fig-3A were quantified by ELISA. C,
4610
4 CD4+ T cells/well cultured in 96-well round bottom plates in the presence of 2 mg/ml of anti-CD3 and 0.8 mg/ml of anti-CD28. IL-1b was added
to these cultures either at the time of culture or twenty four hours later, cell cultures received 5 ng of IL-1b or medium as mentioned. Four days later,
CD4+T cells were subsequently analyzed for Foxp3 expression along with CD4 by flow cytometry. Results shown as a bar graph are mean+SD values
and representative one of three independent experiments carried out in triplicates. One-way analysis of variance was used to determine statistical
significance. * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0021949.g003
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mice suppressed mTg-specific effector T cell response
In order to examine whether self-antigen specific Treg
function can be enhanced with the help of IL-1b,C D 4 +CD25+
T cells enriched from mTg-primed CBA/J mice were activated
using mTg-pulsed splenic DCs with and without IL-1b.A f t e r4
days in culture, a significantly higher proportion of CD4+
CD25+ T cells activated in the presence of IL-1b maintained
Foxp3 expression (Fig. 9A) and produced TGF-b compared to
cells that were activated without IL-1b (Fig. 9C).T oe x a m i n e
Figure 4. The primary effect of IL-1b is on CD4+CD25+ T cells. CD4+25+ and CD4+CD252 T cells were purified from spleens of naı ¨ve C57Bl/6
mice by positive and negative selection respectively, using antibodies bound to magnetic beads. Briefly, CD4+ T cells were isolated by negative
selection using magnetic beads. CD25+ and CD252 T cells were isolated from the CD4+ populations by positive and negative selection respectively.
Purified CD4+, CD25+ and CD252 T cells were stimulated with 2 mg/ml of anti-CD3 and 0.8 mg/ml of anti-CD28. Twenty four hours later, cell cultures
received 5 ng/ml of IL-1b, or medium as control. A, Purified CD4+CD252 T cells and CD4+CD25+ T cells were stained for Foxp3 B, Four days after the
addition of cytokines, cells were analyzed for Foxp3 and TGF-b1 expression along with CD4 by flow cytometry. C, For cytokine analysis, supernatants
from the co-cultures were collected and assayed for TGF-b1 and IL-2. D, CD25+ T cells and GFP+ (Foxp3+) T cells were isolated from wild type C57Bl/6
and Foxp3-GFP KI mice respectively and were stimulated with 2 mg/ml of anti-CD3 and 0.8 mg/ml of anti-CD28. Four days later, cells were analyzed for
Foxp3 or GFP expression along with CD4 by flow cytometry T-test was used to determine statistical differences [None=cultures that received
medium alone and IL-1b=cultures that received IL-1b].
doi:10.1371/journal.pone.0021949.g004
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isolated and co-cultured along with CD4+CD252 cells from
m T g - p r i m e dm i c ea n dm T g - p u l s e dD C s .A so b s e r v e di nF i g .9 C,
Tc e l l sf r o mb o t hI L - 1 b supplemented and control cultures were
able to suppress mTg specific effector T cell proliferation. How-
ever, T cells from IL-1b supplemented cultures exerted superior
suppressor ability on mTg-specific effector T cells compared to
control T cells. These results in conjunction with that shown in
Fig. 8 indicated that IL-1b helps maintain and/or enhance
suppressor function of Tregs irrespective of the activation signal
they receive.
Adoptive transfer of IL-1b-induced Tregs suppress EAT
To examine the therapeutic significance of IL-1b-mediated
maintenance of Foxp3 expression in Tregs and the enhancement
of their suppressor function, CD4+CD25+ T cells from mTg-
primed mice that were cultured with and without IL-1b as
described for Fig. 9 were adoptively transferred into CBA/J
mice prior to inducing experimental autoimmune thyroiditis. As
anticipated, control mice that did not receive T cells developed
severe thyroiditis as indicated by massive infiltration of immune
cells into thyroids and follicular destruction (Fig. 10A). However,
mice that received T cells showed less severe thyroiditis compared
to non-recipient controls. Importantly, mice that received IL-1b-
exposed CD4+CD25+ T cells developed less severe thyroiditis as
compared to control CD4+CD25+ T cell recipients. In addition, T
cells from mice that received both control and IL-1b exposed
CD4+CD25+ T cells showed significantly less ability to proliferate
against mTg challenge ex vivo (Fig. 10B). Cells from CD4+CD25+
T cell recipients produced lesser IFN-c and IL-2, and higher IL-10
and TGF-b1 compared to non-recipient control mice (Fig. 10C).
Importantly, IL-10 and TGF-b1 responses by T cells from mice
that received IL-1b exposed CD4+CD25+ T cells were signifi-
cantly higher than that produced by cells from mice that received
control CD4+CD25+ T cells. These results showed that IL-1b-
treated CD4+CD25+ T cells could promote T cell tolerance to self
antigen and suppress autoimmune thyroiditis more efficiently than
control CD4+CD25+ T cells.
Discussion
CD8a2 DCs from GM-CSF treated mice that produce
significantly lower levels of pro-inflammatory cytokines IL-12
and IL-1b compared to the DCs from control mice can induce
and/or expand Foxp3+ Tregs and suppress autoimmune diseases
[19,35]. While pro-inflammatory cytokines have been generally
associated with the induction of inflammation and autoimmunity,
some studies have shown that they may provide positive signals for
the induction of Tregs [41,42]. Several studies have implicated IL-
12 and other Th1 cytokines in autoimmune diseases [43,44,45,46].
Recent studies have shown IL-1b as an important mediator of
Th17 response in humans and is often associated with autoim-
munity [47,48,49,50]. In contrast, IL-1b has also been shown to
provide co-stimulation and/or act as a growth factor for Foxp3+
Tregs [42,51]. Therefore, in the current study we evaluated the
effects of IL-12 and IL-1b on Foxp3 expression in T cells that were
Figure 5. The induction of Foxp3 by IL-1b is dependent on both IL-2 and TGF-b1. CD4+ T cells that were purified from spleens of naı ¨ve
C57Bl/6 mice were stained with CFSE and cultured in 96-well round bottom plates in the presence of 2 mg/ml of anti-CD3 and 0.8 mg/ml of anti-CD28.
Twenty four hours later these cell cultures received isotype control antibodies (None), or 5 ng/ml of IL-1b along with isotype control antibodies (IL-
1b) and served as controls. Saturating concentrations of neutralizing anti-TGF-b1 (30 mg/ml) or anti-IL-2 (20 mg/ml) were added along with IL-1b. Four
days later, CD4+T cells were analyzed for Foxp3 expression along with CD4 by flow cytometry. These values were compared with values from cultures
that received medium, and t-test was used to determine statistical differences. Results shown are representative of two independent experiments
carried out in triplicates.
doi:10.1371/journal.pone.0021949.g005
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observations showed that these cytokines have contrasting effects
on Foxp3 expression in activated T cells. While the presence of IL-
12 in the culture abrogated Foxp3 expression in T cells, IL-1b in
the presence of reduced levels of IL-12 promoted Foxp3
expression. These results showed that IL-12 and IL-1b have
opposing effects on Tregs. Our results also show that these
secreted factors do not significantly modulate DC properties but
have a direct effect on T cells.
IL-12 is recognized for its ability to promote Th1 type of
pathogenic T cell response in many autoimmune conditions [6,52]
and can overcome immune tolerance by suppressing Foxp3+
Tregs. In a recent study, Brahmachari et al. have shown that the
p40 subunit of IL-12 can down-regulate Foxp3 expression via the
production of nitric oxide [53]. Our observation that IL-12
abrogates Foxp3 expression in T cells during activation further
confirms the pro-inflammatory and the potential pathogenic
effects of this cytokine in autoimmunity.
IL-1b, on the other hand, has pleiotropic effects and can alter
cell signaling, migration and cytokine production, and influence T
cell differentiation differently under different conditions [48,54,
55]. IL-1b has been shown to break peripheral tolerance by
facilitating the expansion of effector T cells and is implicated in
autoimmune diseases such as rheumatoid arthritis [56]. Lately, IL-
1b has been shown to be critical for the generation of IL-17
secreting T helper cells in humans. IL-23 when combined with IL-
1b has been shown to induce and maintain pathogenic Th17 cells
[47,50]. Our current finding of a distinct role for IL-1b in
promoting Foxp3 expression in T cells is in apparent contradiction
to the above findings, but is in agreement with recent observations
of Brinster et al. who showed that IL-1b expands Foxp3+ Tregs in
the presence of anti-CD3 Ab and splenic DCs [51]. In another
study, treatment of murine myeloid DCs with rapamycin, an
immunosuppressive agent, resulted in the production of IL-1b by
phenotypically immature DCs, which were refractive to inflam-
matory stimuli and thus were unable to activate T cell responses
[57]. Moreover, differentiation of DCs from monocytes was
impaired when they were pre-treated with low doses of IL-1b, and
these DCs were unable to effectively stimulate an immune re-
sponse [58]. However, our observations failed to show a significant
Figure 6. Highly purified Foxp3GFP+ Tregs do not proliferate upon treatment with IL-1b.A ,CD4+ T cells from GFP-Foxp3 KI mice were
purified from spleens by negative selection using antibodies bound to magnetic beads. These CD4+ T cells were stained with PE labeled anti-CD25 to
isolate highly purified GFP+CD25+, GFP+CD252, GFP2CD25+ and GFP2CD252 T cells. Percentage purity of sorted cells are shown. These cells
(4610
4 cells/well) were cultured in 96-well round bottom plates in the presence of 2 mg/ml of anti-CD3 and 0.8 mg/ml of anti-CD28. CD4+CD25+ and
CD4+CD252 T cells were isolated from wild type C57Bl/6 mice and were activated as described above. Twenty four hours later, cells were treated
with 5 mg/ml of IL-1b, or medium for 4 days. B, Around 75% of the purified CD25+ T cells were positive for Foxp3. C, Cells were cultured for 48 h and
pulsed for the last 18 h of culture with 1 mCi 3H-thymidine after which they were harvested and assessed for radioactivity. Bar graphs show the mean
cpm + SD of thymidine incorporation in triplicate cultures. These values were compared with those from cultures that received medium, and t-test
was used to determine statistical differences. * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0021949.g006
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PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e21949Figure 7. Production of IL-2 by CD252 T cells and TGF-b1 by CD25+ Tregs is essential for increased in Foxp3+ Tregs upon IL-1b
treatment. A, CD4+ T cells were purified from spleens of naı ¨ve CD45.1+C57Bl/6 and Foxp3.GFP+CD45.2+ mice by negative selection using
antibodies bound to magnetic beads. CD4+CD45.1+ T cells were further sorted into CD25+ and CD252 T cells. Similarly CD4+ T cells from GFP-KI
mice were further sorted into GFP+ and GFP2 T cells. CD25–CD45.1+ and Foxp3.GFP+CD45.2 T cells were cultured alone or together in 96-well
round bottom plates in the presence of 2 mg/ml of anti-CD3 and 0.8 mg/ml of anti-CD28. Twenty four hours later, cell cultures received 5 ng/ml of IL-
1b, or medium as control. Four days later, CD4+T cells were analyzed for Foxp3, IL-2 and TGF-b+ expression after appropriately staining for those
markers. The top two rows indicate the Foxp3, IL-2 and TGF-b1 expression in cells that were gated on CD4+CD45.12 populations while the bottom
two rows show cells that were gated on CD4+CD45.1+ populations. Representative bar graphs show the mean + SD of of results from one of two
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IL-1 receptor transcripts in both DCs and T cells (Figure 1).
Recent studies have shown increased expression of IL-1 receptor
on Tregs as compared to conventional T cells as well as increased
IL-1b signaling in Tregs [2]. Therefore, the higher levels of
expression of IL-1 receptors on T cells may be determined by the
lineage characteristics of T cells and this may have contributed to
the direct effects of IL-1b on T cells noted in this study.
Although nTregs constitutively express Foxp3 during resting
stage, expression level of this transcription factor is down-regulated
upon in vitro activation [59]. This could explain why only less than
50% of CD4+CD25+ T cells expressed Foxp3 after activation in
our control cultures. However, our observations indicate that IL-
1b, when added to the T cell activation cultures, helps maintain
Foxp3 expression in a significantly higher proportion of nTregs
upon activation and proliferation (Fig. 4). This suggested that IL-
1b may be promoting the expansion of naturally existing
CD25+Foxp3+ T cells and/or inducing Foxp3 expression in
CD25+Foxp32 effector T cells. The ability of IL-1b to promote
higher levels of TGF-b1 production by T cells upon activation
suggested that new Foxp3+ T cells could be induced in these
cultures. T cells activated in the presence of IL-1b also produced
significantly higher levels of IL-2 compared to control T cells. This
indicated that these cytokines (i.e. TGF-b1 and IL-2) may have
critical roles in inducing and/or maintaining Foxp3 expression in
T cells that were activated in the presence of IL-1b.
TGF-b is a pleiotropic cytokine that can facilitate either
regulatory or inflammatory responses depending on the levels of
other cytokines present in the microenvironment [60]. While
TGF-b in combination with IL-2 is responsible for the survival of
naı ¨ve T cells and helps maintain peripheral tolerance, it is also
responsible for the differentiation of pathogenic Th17 cells in
association with pro-inflammatory cytokines such as IL-6 [61].
Recent studies have conclusively demonstrated a critical role for
IL-2 not only in the homeostasis and functioning of nTregs, but
also in the generation of adaptive Tregs [62,63,64]. Our observa-
tion that neutralization of IL-2 or TGF-b1 can reverse IL-1b-
dependent increase in Foxp3+ T cell frequencies in the culture
supports the notion that IL-1b promotes TGF-b1 and IL-2
dependent Foxp3 expression in T cells.
independent experiments carried out in triplicate. B, The supernatants from the above cultures were collected and assayed for cytokines TGF-b1 and
IL-2 by ELISA as described for the earlier. Results shown are mean + SD of results from one of two independent experiments carried out in triplicate.
doi:10.1371/journal.pone.0021949.g007
Figure 8. CD4+CD25+ Tregs show increased suppression of effectors upon IL-1b treatment. CD4+ T cells were purified from spleens of
naı ¨ve C57Bl/6 mice using antibodies bound to magnetic beads. CD25+ T cells were further purified using magnetic beads and 2610
5 cells were
cultured in 96-well round bottom plates in the presence of 2 mg/ml of anti-CD3 and 0.8 mg/ml of anti-CD28. Twenty four hours later, cell cultures
received 5 ng/ml of IL-1b or medium (controls). Four days later, 2610
5 CD4+ T cells were isolated and added to CFSE-labeled CD4+CD252 effector T
cells obtained from spleens of naı ¨ve mice at different effector T cell:Treg ratio. Cultures were further stimulated with anti-CD3/anti-CD28. Irradiated
splenocytes from naı ¨ve mice were used as APCs. After 4 days of culture, cell proliferation was assessed by CFSE dilution using flow cytometry. The
CFSE+ population was considered 100%. Cells were gated upon the CFSE-labeled population and the percentage of CFSE
low cells are shown in each
histogram. Results shown are the mean proliferation of CD252 effectors in triplicate cultures and are representative of two independent
experiments. These values were compared with values from cultures that received medium. One way ANOVA was used to determine statistical
significance. * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0021949.g008
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IL-2 upon activation [65]. Therefore, effector T cells are
considered the primary source of IL-2 when total CD4+ T cells
are activated using anti-CD3 and anti-CD28 Abs. Importantly,
although most nTregs constitutively express high levels of CD25
on the surface, a significant proportion of CD4+CD25+ T cells
enriched from normal mice could be Foxp32 activated effector T
cells. This would explain why both CD4+CD25+ and CD4+
CD252 T populations produced considerable amounts of IL-2
upon activation in our study. Our observation that only CD4+
CD25+ T cells, but not CD4+CD252 cells produced TGF-b1
indicated that enriched CD4+CD25+ T cell preparation contains
both Tregs and activated effector T cells, and this population, but
not nTregs or CD4+CD252 cells, can produce significant
amounts both TGF-b1 and IL-2 during activation leading to
induction and/or maintenance of Foxp3 expression in them; the
exogenous IL-1b enhances this effect.
Studies using purified GFP+Foxp3+ cells from Foxp3-GFP
knock-in mice showed little or no proliferation when activated
using anti-CD3 and anti-CD28 Abs with or without IL-1b.
Although a considerable number of Foxp3+ T cells express TGF-
b1 upon activation in the presence of IL-1b, it appears that IL-1b
by itself does not promote Foxp3+ T cell proliferation. The
inability of Foxp3+ cells to proliferate was most likely due to their
failure to produce sufficient amounts of IL-2. In fact earlier studies
have demonstrated that Foxp3+ nTregs require high amounts of
exogenous IL-2 for their proliferation [66]. In this regard,
secretion of much higher amounts of TGF-b1 by CD4+CD25+
T cells, upon activation in the presence of IL-1b, suggested that it
likely acted as an autocrine and helped sustain Foxp3 expression,
while IL-2 secreted by Foxp32CD25+ T cells facilitated pro-
liferation of Foxp3+ cells. In fact, a recent study has shown that IL-
1b-induced IL-2 production by Foxp32 T cells is essential for IL-
1b-mediated expansion of Foxp3 T cells [51].
Very little is known about how IL-1b regulates IL-2 and TGF-b
production. While studies have reported a negative correlation
between IL-1b and TGF-b [67,68,69], Tao Lu et al. showed that
TGF-b and IL-1b cross activate each other in a dose-dependent
manner [70]. Earlier studies have also shown the induction of
TGF-b by IL-1b in different human and animal tissues [71,72,73].
Figure 9. IL-1b treated Tregs show increased antigen specific suppression in vitro. CD4+CD25+ T cells were isolated from mTg-immunized
mice and cultured in the presence of splenic DCs as antigen-presenting cells, IL-1b or medium and mTg (100 mg/ml). A, After 4 days, CD4+ T cells
were purified and evaluated for Foxp3 expression and B, secreted TGF-b1 in supernatants by ELISA. C, These cells were added to CFSE-stained
CD4+CD252 T effector cells isolated form mTg purified mice in the presence of mTg (100 mg/ml). The percentage of CFSE
low cells are shown in each
histogram (lower panel). (mTg-immunized Teff=CD4+CD252 T cell cultures that received mTg). Bar graphs show the mean proliferation + SD of
CD252 effectors in triplicate cultures. One way ANOVA was used to determine statistical significance.
doi:10.1371/journal.pone.0021949.g009
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PLoS ONE | www.plosone.org 13 July 2011 | Volume 6 | Issue 7 | e21949Figure 10. IL-1b treated Tregs from mTg-primed mice more efficiently suppress autoimmune thyroiditis. CD4+ T cells were purified
from spleens of naı ¨ve CBA/J mice using antibodies bound to magnetic beads. CD25+ T cells were further purified using magnetic beads and cultured
in 96-well round bottom plates in the presence of 2 mg/ml of anti-CD3 and 0.8 mg/ml of anti-CD28. Twenty four hours later, cell cultures received
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chondrocytes through the activation of AP-4 and AP-1 binding to
the TGF-b1 gene promoter [72]. Therefore, it appears that IL-1b
and TGF-b regulate the expression of each other in different
immune cells, and that this regulation is dependent upon their
absolute and relative concentrations as well as on the presence of
other cytokines such as IL-2. Our observation that TGF-b
secretion and Foxp3 expression by Tregs is dependent on the
concentration of IL-1b as well as presence of IL-2 in the culture
supports this notion. While we have no direct evidence on the
regulation of IL-2 production by IL-1b, the increased IL-2
production by effector T cells in the presence of IL-1b is likely the
result of this cytokine’s ability to enhance T cell proliferation upon
activation.
Overall, our observations show that IL-1b can 1) enhance the
proliferation of effector T cells upon activation, 2) increase the
production of IL-2 by these proliferating cells, 3) enhance the
activation and proliferation of Foxp3+ cells in the presence of IL-2
from effector T cells, 4) increase the production of TGF-b1b y
Foxp3+ cells and 5) promote IL-2 and TGF-b1 dependent Foxp3
expression in both Tregs and effector T cells. The observation that
IL-1b-exposed CD4+CD25+ cells can suppress effector T cell
response in vitro and autoimmune thyroiditis in CBA/j mice
suggest that the increase in the frequency of Foxp3+ Tregs in IL-
1b-treated cultures may account for the enhanced suppression of
autoimmune response when compared to controls. It must be
noted that the control Tregs could also suppress autoimmune
disease but to a lesser extent.
In conclusion, our study demonstrates a new role for IL-1b in
promoting and enhancing Treg function. Considering that this
cytokine is also produced during inflammatory responses, it is
reasonable to assume that IL-1b has an immunoregulatory role.
Based on our observations, we speculate that one of the functions
of IL-1b produced during an inflammation may be to promote the
suppressor function of Tregs to avoid autoimmune and lympho-
proliferative responses.
Supporting Information
Figure S1 Purified DCs and T cells, both express IL-R
with and without treatment with IL-1b. Purified CD11c+
DCsand CD4+ T cells were purified from spleens of naı ¨ve C57Bl/6
mice using antibodies bound to magnetic beads. To determine IL-
1b receptor expression on the surface of T cells and DCs with or
without treatment with IL-1b, T cells and DCs were isolated using
magnetic beads and cultured in the presence of 5 ng of IL-1b or
medium alone for 24 hours. Subsequently, RNA was isolated from
these cells and used in a RT-PCR assay to detect cytokine
transcripts for IL-R2. Primers to detect HPRT were used as
controls. PCR products were collected at different cell cycles and
wereresolved on a 2% agarose gel. Primer sequences are: HPRT-F-
GTTGGATACAGGCCAGACTTTGTTG, HPRT-R-TACTA-
GGCAGATGGCCAGGACTA; IL-1R2F-TGCAAAGTGTTT-
CTGGGAAC, IL-1R2R-ATATTGCCCCCACAACCAAG.
(TIF)
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